3-isopropyl-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)benzo[d]isoxazol-6-amine

ID: ALA4551081

PubChem CID: 134190246

Max Phase: Preclinical

Molecular Formula: C16H15N5O

Molecular Weight: 293.33

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CC(C)c1noc2cc(Nc3n[nH]c4cccnc34)ccc12

Standard InChI:  InChI=1S/C16H15N5O/c1-9(2)14-11-6-5-10(8-13(11)22-21-14)18-16-15-12(19-20-16)4-3-7-17-15/h3-9H,1-2H3,(H2,18,19,20)

Standard InChI Key:  PXRSGEZVSDEGOG-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 22 25  0  0  0  0  0  0  0  0999 V2000
   28.1422   -9.1335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1410   -9.9531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8491  -10.3620    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.8473   -8.7247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5559   -9.1299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5607   -9.9485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3407  -10.1970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8181   -9.5319    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.3330   -8.8725    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.5978  -10.9727    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.3981  -11.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6499  -11.9137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7327  -10.6894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9338  -10.5277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9935  -11.4683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4525  -12.0803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8673  -12.7840    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.6648  -12.6069    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.7427  -11.7938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4467  -11.3788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1581  -11.7810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4392  -10.5617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  7 10  1  0
 10 11  1  0
 11 12  2  0
 12 16  1  0
 15 13  1  0
 13 14  2  0
 14 11  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 15  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4551081

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 293.33

Molecular Weight (Monoisotopic): 293.1277

AlogP: 3.97

#Rotatable Bonds: 3

Polar Surface Area: 79.63

Molecular Species: NEUTRAL

HBA: 5

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 12.88

CX Basic pKa: 2.54

CX LogP: 3.26

CX LogD: 3.26

Aromatic Rings: 4

Heavy Atoms: 22

QED Weighted: 0.60

Np Likeness Score: -1.48

References

1. Bollinger SR, Engers DW, Panarese JD, West M, Engers JL, Loch MT, Rodriguez AL, Blobaum AL, Jones CK, Thompson Gray A, Conn PJ, Lindsley CW, Niswender CM, Hopkins CR..  (2018)  Discovery, Structure-Activity Relationship, and Biological Characterization of a Novel Series of 6-((1 H-Pyrazolo[4,3- b]pyridin-3-yl)amino)-benzo[ d]isothiazole-3-carboxamides as Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 4 (mGlu₄).,  62  (1): [PMID:30247901] [10.1021/acs.jmedchem.8b00994]

Source

Source(1):

• Scientific Literature